Yield of Screening for CADASIL Mutations in Lacunar Stroke and Leukoaraiosis
Open Access
- 1 January 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (1) , 203-206
- https://doi.org/10.1161/01.str.0000048162.16852.88
Abstract
Background and Purpose— Cerebral autosomal dominant arteriopathy subcortical infarcts and leukoencephalopathy (CADASIL) is a monogenic disorder typified by early onset lacunar strokes, subcortical dementia, psychiatric disturbances, and migraine. Mutations in the Notch3 gene are responsible. Atypical phenotypes have been recognized, and the disease is probably underdiagnosed in the wider stroke population. Therefore, we determined the yield of screening for Notch3 mutations in lacunar stroke with or without leukoaraiosis. Methods— Two hundred eighteen consecutive patients were studied. All had brain and carotid imaging. Polymerase chain reaction-single-stranded conformational polymorphism analysis was used to screen exons 3, 4, 5, and 6 of the Notch3 gene for mutations and polymorphisms. Results— A single mutation in exon 4 (C697T) was identified in a young patient, giving an overall carrier frequency of 0.05% (95% CI, 0.0 to 2.0). For patients with onset of lacunar stroke at ≤65 years and leukoaraiosis, the yield was 2.0% (95% CI, 0.4 to 10.9). Conclusions— Notch3 mutations are rare in patients with typical strokes due to cerebral small-vessel disease. In the absence of classic features suggestive of CADASIL, screening for Notch3 mutations has a low yield.Keywords
This publication has 20 references indexed in Scilit:
- Notch3 gene polymorphism and ischaemic cerebrovascular diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Incidence of Dementia, Alzheimer's Disease, and Vascular Dementia in Italy. The ILSA StudyJournal of the American Geriatrics Society, 2002
- Hyperhomocysteinemia in Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)Mayo Clinic Proceedings, 2001
- Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosisThe Lancet, 2001
- Description of a simple test for CADASIL disease and determination of mutation frequencies in sporadic ischaemic stroke and dementia patientsJournal of Neurology, Neurosurgery & Psychiatry, 2000
- CADASIL: hereditary disease of arteries causing brain infarcts and dementiaNeuropathology and Applied Neurobiology, 1999
- The phenotypic spectrum of CADASIL: Clinical findings in 102 casesAnnals of Neurology, 1998
- Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementiaNature, 1996
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal agingAmerican Journal of Roentgenology, 1987